Furthermore, in December 2025, the FDA approved the oral Wegovy pill, catering to patients who prefer a non-injectable option
Contraindications XIGDUO XR is contraindicated in patients with: Severe renal impairment (eGFR below 30 mL/min/1.73 m2) or end-stage renal disease [see Warnings and Precautions (5.1)]
2022;1665:462832 [CrossRef] [Google Scholar] A review of the modern principles and applications of solid-phase extraction techniques in chromatographic analysis
However, this was achieved using intraperitoneal injections with alum adjuvant, which likely contributed to the observed immunogenicity [56]
The American Diabetes Association's Standards of Care acknowledge the ongoing uncertainty, noting that while pancreatitis has been reported with GLP-1 receptor agonist use, a definitive causal relationship has not been established
GLP-1 and GIP receptor agonistsare unlikely to cause severe hypoglycemia unless combined with other medications for diabetes